Intellus Worldwide Summit round up 2019
This May, Liza Pliss, Director and Head of our New York Office, Sabera Hyderally, Director, Head of MedTech Division North America and Emily Hoffman, Associate Director exhibited at and attended the Intellus Worldwide Summit in Philadelphia.
Intellus Worldwide Summit 2019
Visit us at stand 311
We are delighted to be exhibiting at the Intellus Worldwide Summit in Philadelphia, USA from 19th-21st May. Representing Research Partnership at the event will be Liza Pliss, Director and Head of our New York Office, Sabera Hyderally, Director, Head of MedTech Division North America and Emily Hoffman, Associate Director.
The vaccine opportunity in Asia infographic
Asia is the home to 60% of the world’s population and is one of the fastest growing vaccine markets in the world. A rising demand for better healthcare infrastructure and high awareness levels of the benefits of immunisation are the major factors boosting the vaccine market growth. For World Immunisation Week 2019 we have updated one of our most popular infographics, in which we explore the vaccine opportunity in Asia, packed full with all of the latest facts and figures from the region.
China in the Fast Lane: How to play and win in the world's hottest emerging market
Watch this webcast where Marc Yates and Helen Ansell explore China's evolving healthcare envrinoment. The webcast highlights the key changes affecting pharma and demonstrates how to build the market understanding required to launch a brand effectiviely in this exciting region.
How we helped our client to understand the opportunities across Asia and other emerging markets using interactive outputs
Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low / sub-optimal.
Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low and sub optimimal. Research was required to understand the diabetic patient journey in order to assess the opportunities to expand HCP knowledge on the importance of lipid lowering for type 2 diabetes patients. The client also wanted to explore the drivers and barriers which would influence uptake.